|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 2,317.00 DKK | +0.65% |
|
+1.67% | +14.31% |
| 09-29 | Nordic stocks in North America - Ericsson rose 1.7 percent | FW |
| 09-24 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| Market Cap | 138B 20.99B 18.52B 17.52B 15.89B 29.79B 2,014B 30.09B 210B 81.02B 1,028B 78.8B 77.09B 3,309B | P/E 2026 * |
28.9x | P/E 2027 * | 20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 158B 23.9B 21.09B 19.96B 18.1B 33.93B 2,293B 34.26B 239B 92.26B 1,171B 89.74B 87.79B 3,769B | EV / Sales 2026 * |
5.43x | EV / Sales 2027 * | 4.44x |
| Free-Float |
94.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| GMAB | Delayed | |
CBOE
| GMABc | Real-time | |
London S.E.
| 0MGB | Delayed | |
OTC Markets
| GNMSF | Delayed | |
Xetra
| GE9 | End-of-day quote | |
Xetra
| GE9 | Delayed | |
Tradegate
| GE9 | Real-time | |
Mexican S.E.
| GMAB N | End-of-day quote | |
Boerse Muenchen
| GE9 | Real-time | |
CBOE
| 0MGB | Real-time | |
Deutsche Boerse AG
| GE9 | Delayed | |
Börse Stuttgart
| GE9 | Delayed | |
Wiener Boerse
| GMAB | End-of-day quote |
Last Transcript: Genmab A/S
| 1 day | +0.65% | ||
| 1 week | +1.67% | ||
| Current month | +9.19% | ||
| 1 month | +7.47% | ||
| 3 months | +34.83% | ||
| 6 months | +37.71% | ||
| Current year | +14.31% |
| 1 week | 2,256 | 2,340 | |
| 1 month | 2,066 | 2,340 | |
| Current year | 1,512 | 2,340 | |
| 1 year | 1,512 | 2,340 | |
| 3 years | 1,157 | 2,532 | |
| 5 years | 1,157 | 3,327 | |
| 10 years | 786.2 | 3,327 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2010-05-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 2020-02-29 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 2003-10-31 | |
| Director/Board Member | 58 | 2014-12-31 | |
| Director/Board Member | 75 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/1/25 | Exercice | Director | 189 | 0.0003% | ||
| 12/1/25 | Exercice | Director | 189 | 0.0003% | ||
| 12/1/25 | Exercice | Director | 283 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.65% | +1.67% | +26.47% | -7.62% | 20.92B | ||
| -0.70% | -4.28% | +52.62% | +86.42% | 71.81B | ||
| +0.45% | -0.82% | +38.81% | +84.19% | 60.06B | ||
| +2.34% | +3.60% | +33.48% | +23.06% | 27.93B | ||
| -1.73% | -4.30% | -18.37% | +357.94% | 25.7B | ||
| -0.51% | -2.28% | +0.48% | -9.27% | 24.89B | ||
| +3.46% | +3.02% | +158.90% | +337.81% | 15.04B | ||
| +0.48% | +0.86% | +44.56% | +168.42% | 14.46B | ||
| +0.34% | -1.74% | -7.67% | +503.82% | 13.87B | ||
| +5.88% | -4.26% | -22.54% | +776.47% | 12.35B | ||
| Average | +0.38% | -1.67% | +30.68% | +232.13% | 28.7B | |
| Weighted average by Cap. | +0.17% | -1.95% | +34.10% | +156.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29.02B 4.4B 3.88B 3.67B 3.33B 6.24B 422B 6.31B 44.06B 16.98B 216B 16.52B 16.16B 694B | 33.67B 5.1B 4.5B 4.26B 3.86B 7.25B 490B 7.32B 51.12B 19.7B 250B 19.17B 18.75B 805B |
| Net income | 4.98B 755M 666M 630M 571M 1.07B 72.42B 1.08B 7.56B 2.91B 36.98B 2.83B 2.77B 119B | 7.1B 1.08B 950M 899M 815M 1.53B 103B 1.54B 10.78B 4.16B 52.75B 4.04B 3.95B 170B |
| Net Debt | 19.22B 2.91B 2.57B 2.43B 2.21B 4.14B 280B 4.18B 29.18B 11.25B 143B 10.94B 10.7B 459B | 11.06B 1.68B 1.48B 1.4B 1.27B 2.38B 161B 2.4B 16.79B 6.47B 82.12B 6.29B 6.16B 264B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | DKK 2,317.00 | +0.65% | 142,718 |
| 26-09-28 | DKK 2,302.00 | +1.10% | 122,997 |
| 26-09-25 | DKK 2,277.00 | +0.40% | 99,355 |
| 26-09-24 | DKK 2,268.00 | -1.05% | 79,887 |
| 26-09-23 | DKK 2,292.00 | +0.57% | 118,274 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions




















